ChemicalBook--->CAS DataBase List--->2579031-19-7

2579031-19-7

2579031-19-7 Structure

2579031-19-7 Structure
IdentificationBack Directory
[Name]

Empasiprubart
[CAS]

2579031-19-7
[Synonyms]

Empasiprubart
Research Grade Empasiprubart (DHC20401)
Chemical PropertiesBack Directory
[form ]

Liquid
[color ]

Colorless to light yellow
Hazard InformationBack Directory
[Uses]

Empasiprubar (ARGX-117) is a humanized inhibitory monoclonal antibody targeting complement C2. Empasiprubar binds to the Sushi-2 domain of C2, preventing the formation of C3 pre convertase and inhibiting the activation of classical and lectin pathways upstream of C3 activation. Empasiprubar can prevent complement mediated autoimmune hemolytic anemia and antibody mediated organ transplant rejection. Empasiprubar can prevent neuroglial lymphoconjunctival injury in GM1 antibody mediated mouse models[1][2].
[in vivo]

Empasiprubart (0.5-30 mg/kg; once daily; 60 days; i.v.) targets the classical pathway (CP) and lectin pathway (LP) inhibition in crab eating macaques, without affecting the alternative pathway (AP)[1]. Empasiprubart (200 mg/kg; once; i.v.) can prevent neuroglial lymphoconjunctival injury in GM1 antibody mediated mouse models[2].

Animal Model:Cynomolgus monkeys[1].
Dosage:0.5-30 mg/kg
Administration:Intravenous injection (i.v.); once daily; 60 days
Result:Reduced free C2 levels and classical pathway activity.
Animal Model:Schwann cell nodal membrane injury mice model[2].
Dosage:200 mg/kg
Administration:Intravenous injection (i.v.); once
Result:Attenuated injury to paranodal proteins at the node of Ranvier and improves respiratory function in vivo Schwann cell nodal membrane injury models.
[References]

[1] Van de Walle I, et al. ARGX-117, a therapeutic complement inhibiting antibody targeting C2. J Allergy Clin Immunol. 2021 Apr;147(4):1420-1429.e7. DOI:10.1016/j.jaci.2020.08.028
[2] Campbell CI, et al. Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model. Brain Commun. 2022 Nov 23;4(6):fcac306. DOI:10.1093/braincomms/fcac306
[3] Budding K, et al. Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 10;9(1):e1107. DOI:10.1212/NXI.0000000000001107
2579031-19-7 suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 13636370518
Website: www.shyuanye.com
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Website: www.biochempartner.com
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Website: http://www.hezefdc.com/ShowSupplierProductsList1222417/0_EN.htm
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Website: http://www.chemstan.com/
Company Name: Biolab Reagents  
Tel: 027-65279366 18108604356
Website: www.biolabreagent.com/
Company Name: Wuhan Acumen Bio-Technology Co.,ltd  
Tel: 027-027-16602739303 16602739303
Website: www.yjybiochem.com/
Company Name: Wanxin Biotechnology (Jiaxing) Co., LTD  
Tel: 0573-83568680 18057391398
Website:
Company Name: Atagenix Laboratories  
Tel: 027-87008169 17762441161
Website: www.abinscience.com/
Company Name: Chengdu Peter-like Biotechnology Co., Ltd.  
Tel: 028-81700200 13308200041
Website: www.weikeqi-biotech.com/
Company Name: AntibodySystem Laboratories SAS  
Tel: 33175446423
Website: www.antibodysystem.com
Company Name: Wuhan Maixi Biotechnology Co., Ltd  
Tel: 18007167883 18007167883
Website: www.mabnus.cn
Company Name: TargetMol  
Tel: 400-821-0310 15002144251
Website: www.targetmol.cn/
Tags:2579031-19-7 Related Product Information